Michael J. Blaha, MD

Dr. Michael J. Blaha MD MPH (Professor of Cardiology and Epidemiology) is the Director of Clinical Research and Director of the Cardiometabolic Clinic for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease.  Clinically, he practices as a preventive cardiologist and in the interpretation of non-contrast and contrasted cardiac CT.  His clinic specializes in patients with advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk.  Dr. Blaha has published over 550 scientific articles, with a focus on appropriate use of tests and new therapies in the prevention of atherosclerotic cardiovascular disease as a function of atherosclerosis burden.  He has served as an Associate Editor for the journals Atherosclerosis and Journal of Cardiovascular Computed Tomography, Associate Editor for the Diabetes and Cardiometabolic Clinical Community for the ACC.org, and is a standing member of the Endocrinologic and Metabolic Drug Advisory Committee (EMDAC) for the FDA.  He has received multiple grant awards from the National Institutes of Health, FDA, American Heart Association, Amgen Foundation, Aetna Foundation, Bayer, and Novo Nordisk.  In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring.  He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 0.1% of world’s researchers.